What's new

Human medicines European public assessment report (EPAR): Rivastigmine Sandoz, rivastigmine, Date of authorisation: 10/12/2009, Revision: 18, Status: Authorised

Human medicines European public assessment report (EPAR): Rivastigmine Sandoz, rivastigmine, Date of authorisation: 10/12/2009, Revision: 18, Status: Authorised

Apr 4, 2025 - 14:06
 0
Human medicines European public assessment report (EPAR): Rivastigmine Sandoz, rivastigmine, Date of authorisation: 10/12/2009, Revision: 18, Status: Authorised
Human medicines European public assessment report (EPAR): Rivastigmine Sandoz, rivastigmine, Date of authorisation: 10/12/2009, Revision: 18, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Avtozma, tocilizumab, ...

Next Article

Secretary General reaffirms security through strength and support to Ukraine, as...

Related Posts

Human medicines European public assessment report (EPAR): Strimvelis, autologous CD34+ enriched cell fraction that contains CD34+ cells transduced with retroviral vector that encodes for the human ADA cDNA sequence, Date of authorisation: 26/05/2016, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 27, 2025  0

Scientific advice under Article 115(5) of Regulation (E...

Mar 14, 2025  0

Human medicines European public assessment report (EPAR): Zoely, nomegestrol,estradiol, Date of authorisation: 26/07/2011, Revision: 25, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 19, 2025  0